These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 19586653)
1. Periurethral non-animal stabilized hyaluronic acid/dextranomer injections: efficacy and formation of granuloma/sterile abscess. Sahai A; Thomas M; Nedas T; Larner T; Niekrash R; Hammadeh MY Urology; 2009 Sep; 74(3):486-8. PubMed ID: 19586653 [No Abstract] [Full Text] [Related]
2. Urethrovaginal fistula associated with 'sterile abscess' formation following periurethral injection of dextranomer/hyaluronic acid co-polymer (Zuidex) for the treatment of stress urinary incontinence--a case report. Hilton P BJOG; 2009 Oct; 116(11):1527-30. PubMed ID: 19681847 [No Abstract] [Full Text] [Related]
3. Periurethral granuloma following injection with dextranomer/hyaluronic acid copolymer for stress urinary incontinence. Castillo-Vico MT; Checa-Vizcaíno MA; Payà-Panadés A; Rueda-García C; Carreras-Collado R Int Urogynecol J Pelvic Floor Dysfunct; 2007 Jan; 18(1):95-7. PubMed ID: 16328113 [TBL] [Abstract][Full Text] [Related]
4. Obstructive suburethral mass following injection of dextranomer/hyaluronic acid copolymer. Fatton B; Savary D; Velemir L Int J Gynaecol Obstet; 2009 Jan; 104(1):73-4. PubMed ID: 18926538 [No Abstract] [Full Text] [Related]
5. [Paraurethral abscess developing after mid-urethral Zuidex-injection in women with stress urinary incontinence -- management of complications and retrospective comparison with bladder neck located injection technique]. Hagemeier T; Blau U; Gauruder-Burmester A; Tunn R Zentralbl Gynakol; 2006 Apr; 128(2):68-70. PubMed ID: 16673247 [TBL] [Abstract][Full Text] [Related]
6. [Periurethral pseudocysts following urethral injections of Zuidex: review of the literature]. Loisel C; Secco M; Rocher-Barrat A; Caremel R; Grise P Prog Urol; 2008 Dec; 18(13):1038-43. PubMed ID: 19041807 [TBL] [Abstract][Full Text] [Related]
7. Simple aspiration technique to address voiding dysfunction associated with transurethral injection of dextranomer/hyaluronic acid copolymer. Petrou SP; Pak RW; Lightner DJ Urology; 2006 Jul; 68(1):186-8. PubMed ID: 16777199 [TBL] [Abstract][Full Text] [Related]
8. Obstructive suburethral mass after transurethral injection of dextranomer/hyaluronic acid copolymer. Abdelwahab HA; Ghoniem GM Int Urogynecol J Pelvic Floor Dysfunct; 2007 Nov; 18(11):1379-80. PubMed ID: 17437054 [TBL] [Abstract][Full Text] [Related]
9. [Periurethral injections of dextranomer/hyaluronic acid copolymer in the treatment of female stress urinary incontinence: description of the technique and bibliographic review]. Moreno Sierra J; Alonso Prieto MA; Fernández Montarroso L; Pérez Romero N; Hernández Sánchez E; Galante Romo I; Prieto Nogal S; Salinas Casado J; Silmi Moyano A Arch Esp Urol; 2006 Sep; 59(7):713-8. PubMed ID: 17078395 [TBL] [Abstract][Full Text] [Related]
10. Periurethral pseudoabscess secondary to injection of an intraurethral bulking agent. Fanning DM; Flood H BMJ Case Rep; 2011 Dec; 2011():. PubMed ID: 22669954 [No Abstract] [Full Text] [Related]
11. Cystoscopic injections of dextranomer hyaluronic acid into proximal urethra for urethral incompetence: efficacy and adverse outcomes. Lightner DJ; Fox J; Klingele C Urology; 2010 Jun; 75(6):1310-4. PubMed ID: 20299087 [TBL] [Abstract][Full Text] [Related]
12. Urethral injection for stress urinary incontinence: long-term results with dextranomer/hyaluronic acid copolymer. Stenberg AM; Larsson G; Johnson P Int Urogynecol J Pelvic Floor Dysfunct; 2003 Nov; 14(5):335-8; discussion 338. PubMed ID: 14618311 [TBL] [Abstract][Full Text] [Related]
13. Long-term outcome of transurethral injection of hyaluronic acid/dextranomer (NASHA/Dx gel) for the treatment of stress urinary incontinence (SUI). Lone F; Sultan AH; Thakar R Int Urogynecol J; 2010 Nov; 21(11):1359-64. PubMed ID: 20571764 [TBL] [Abstract][Full Text] [Related]
14. Endoscopic repair of post-traumatic fistulae of posterior urethra using hyaluronic acid dextranomer. Appignani A; Bertozzi M; Prestipino M Urology; 2010 Jul; 76(1):109-11. PubMed ID: 19963253 [TBL] [Abstract][Full Text] [Related]
15. Patient-perceived outcomes in the treatment of stress urinary incontinence: focus on urethral injection therapy. Chapple CR; Brubaker L; Haab F; van Kerrebroeck P; Robinson D Int Urogynecol J Pelvic Floor Dysfunct; 2007 Feb; 18(2):199-205. PubMed ID: 16847584 [TBL] [Abstract][Full Text] [Related]
16. Giant cell reaction with phagocytosis adjacent to dextranomer-hyaluronic acid (Deflux) implant: possible reason for Deflux failure. Broderick K; Thompson JH; Khan AR; Greenfield SP J Pediatr Urol; 2008 Aug; 4(4):319-21. PubMed ID: 18644540 [No Abstract] [Full Text] [Related]
18. Efficacy and safety of a novel system (NASHA/Dx copolymer using the Implacer device) for treatment of stress urinary incontinence. van Kerrebroeck P; ter Meulen F; Larsson G; Farrelly E; Edwall L; Fianu-Jonasson A Urology; 2004 Aug; 64(2):276-81. PubMed ID: 15302478 [TBL] [Abstract][Full Text] [Related]
19. Obstruction of a dysmorphic ureter following dextranomer/hyaluronic acid copolymer. Snodgrass WT J Urol; 2004 Jan; 171(1):395-6. PubMed ID: 14665941 [No Abstract] [Full Text] [Related]